Long-term follow-up of children with high-risk neuroblastoma: The ENSG5 trial experience

Background Therapy for high‐risk neuroblastoma is intensive and multimodal, and significant long‐term adverse effects have been described. The aim of this study was to identify the nature and severity of late complications of metastatic neuroblastoma survivors included in the ENSG5 clinical trial. P...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2013-07, Vol.60 (7), p.1135-1140
Hauptverfasser:	Moreno, Lucas, Vaidya, Sucheta J., Pinkerton, C. Ross, Lewis, Ian J., Imeson, John, Machin, David, Pearson, Andrew D. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Child Child, Preschool Female Follow-Up Studies Hematology Humans Infant late effects long-term survivors Male Neoplasms, Second Primary - epidemiology neuroblastoma Neuroblastoma - drug therapy Oncology Pediatrics second malignancies Survivors - statistics & numerical data Time Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!